AI assistant
Sending…
ORACLE CORP — Director's Dealing 2013
Oct 24, 2013
29742_dirs_2013-10-24_99cf7f13-f375-4640-9282-2ff524b41500.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ORACLE CORP (ORCL)
CIK: 0001341439
Period of Report: 2013-10-22
Reporting Person: Kurian Thomas (EVP-Product Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-10-22 | Common Stock | M | 232616 | $21.04 | Acquired | 264943 | Direct |
| 2013-10-22 | Common Stock | S | 232616 | $33.1046 | Disposed | 32327 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-10-22 | Stock Option | $21.04 | M | 232616 | Disposed | 2019-07-02 | Common Stock (232616) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $33.10 to $33.125. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: Option vests 25% annually on anniversary of grant date.
More from ORACLE CORP
Regulatory Filings
2026
May 12
Regulatory Filings
2026
Apr 6
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 11
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 4
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Feb 2